CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Dominari Holdings Inc. - DOMH CFD

    2.35
    0%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.10
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 2.35
    Open* 2.34
    1-Year Change* -65.74%
    Day's Range* 2.34 - 2.35
    52 wk Range 2.06-7.27
    Average Volume (10 days) 6,030.00
    Average Volume (3 months) 232.55K
    Market Cap 14.49M
    P/E Ratio -100.00K
    Shares Outstanding 5.35M
    Revenue 71.00K
    EPS -4.99
    Dividend (Yield %) N/A
    Beta 0.97
    Next Earnings Date Nov 15, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Sep 29, 2023 2.35 0.01 0.43% 2.34 2.35 2.34
    Sep 28, 2023 2.35 0.06 2.62% 2.29 2.41 2.29
    Sep 27, 2023 2.38 -0.01 -0.42% 2.39 2.45 2.31
    Sep 26, 2023 2.35 0.07 3.07% 2.28 2.35 2.28
    Sep 25, 2023 2.30 -0.14 -5.74% 2.44 2.44 2.27
    Sep 22, 2023 2.40 -0.05 -2.04% 2.45 2.45 2.40
    Sep 21, 2023 2.44 -0.08 -3.17% 2.52 2.52 2.44
    Sep 20, 2023 2.54 0.15 6.28% 2.39 2.86 2.39
    Sep 19, 2023 2.45 0.05 2.08% 2.40 2.49 2.34
    Sep 18, 2023 2.54 -0.15 -5.58% 2.69 2.69 2.54
    Sep 15, 2023 2.64 -0.05 -1.86% 2.69 2.69 2.64
    Sep 14, 2023 2.59 -0.01 -0.38% 2.60 2.73 2.55
    Sep 13, 2023 2.63 -0.03 -1.13% 2.66 2.73 2.61
    Sep 12, 2023 2.69 0.03 1.13% 2.66 2.70 2.66
    Sep 11, 2023 2.69 0.00 0.00% 2.69 2.74 2.69
    Sep 8, 2023 2.69 0.01 0.37% 2.68 2.70 2.68
    Sep 7, 2023 2.70 -0.03 -1.10% 2.73 2.74 2.70
    Sep 6, 2023 2.57 0.00 0.00% 2.57 2.57 2.57
    Sep 5, 2023 2.62 -0.06 -2.24% 2.68 2.68 2.56
    Sep 1, 2023 2.72 -0.04 -1.45% 2.76 2.86 2.72

    Dominari Holdings Inc. Events

    Time (UTC) Country Event
    Wednesday, November 15, 2023

    Time (UTC)

    21:00

    Country

    US

    Event

    Q3 2023 Aikido Pharma Inc Earnings Release
    Q3 2023 Aikido Pharma Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0 0 0.009 0.028
    Revenue 0 0.009 0.028
    Total Operating Expense 14.346 9.441 6.546 5.694 6.902
    Selling/General/Admin. Expenses, Total 11.683 7.734 4.057 3.172 3.056
    Depreciation / Amortization 1.443
    Unusual Expense (Income) 0 2.403
    Operating Income -14.346 -9.441 -6.546 -5.685 -6.874
    Interest Income (Expense), Net Non-Operating -7.825 2.135 -5.81 1.502 8.601
    Net Income Before Taxes -22.107 -7.171 -12.337 -4.183 1.727
    Net Income After Taxes -22.107 -7.171 -12.337 -4.183 1.727
    Net Income Before Extra. Items -22.107 -7.171 -12.337 -4.183 1.727
    Net Income -22.107 -7.171 -12.337 -4.183 1.727
    Total Adjustments to Net Income -4.109
    Income Available to Common Excl. Extra. Items -26.216 -7.171 -12.337 -4.183 1.727
    Income Available to Common Incl. Extra. Items -26.216 -7.171 -12.337 -4.183 1.727
    Diluted Net Income -26.216 -7.171 -12.337 -4.183 1.727
    Diluted Weighted Average Shares 5.33408 4.84667 1.65142 0.14773 0.11157
    Diluted EPS Excluding Extraordinary Items -4.91482 -1.47957 -7.47055 -28.3151 15.4797
    Diluted Normalized EPS -4.91482 -1.47957 -7.47055 -28.3151 37.0186
    Total Extraordinary Items
    Research & Development 2.663 1.707 2.489 2.522
    Other, Net 0.064 0.135 0.019
    Dividends per Share - Common Stock Primary Issue 0
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0.071 0 0 0 0
    Total Operating Expense 9.082 3.834 3.144 5.101 2.298
    Selling/General/Admin. Expenses, Total 9.08 3.833 3.119 4.515 2.262
    Research & Development 0.002 0.001 0.025 0.586 0.036
    Operating Income -9.011 -3.834 -3.144 -5.101 -2.298
    Interest Income (Expense), Net Non-Operating 0.56 0.072 -4.112 -1.138 -2.779
    Other, Net -0.212 0 0 0 0
    Net Income Before Taxes -8.663 -3.762 -7.256 -6.239 -5.077
    Net Income After Taxes -8.663 -3.762 -7.256 -6.239 -5.077
    Net Income Before Extra. Items -8.663 -3.762 -7.256 -6.239 -5.077
    Net Income -8.663 -3.762 -7.256 -6.239 -5.077
    Income Available to Common Excl. Extra. Items -8.663 -3.762 -7.256 -6.239 -6.177
    Income Available to Common Incl. Extra. Items -8.663 -3.762 -7.256 -6.239 -6.177
    Diluted Net Income -8.663 -3.762 -7.256 -6.239 -6.177
    Diluted Weighted Average Shares 4.82724 5.30551 5.48675 5.34499 5.25102
    Diluted EPS Excluding Extraordinary Items -1.79461 -0.70907 -1.32246 -1.16726 -1.17634
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -1.79461 -0.70907 -1.32246 -1.16726 -1.17634
    Total Adjustments to Net Income 0 0 0 0 -1.1
    Revenue 0.071
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 50.656 90.889 27.731 1.129 2.905
    Cash and Short Term Investments 42.317 83.463 27.516 0.948 2.717
    Cash & Equivalents 0.091 0.017
    Short Term Investments 9.143 13.7 24.801 0.857 2.7
    Prepaid Expenses 0.865 0.442 0.215 0.181 0.188
    Total Assets 76.236 102.656 30.495 11.282 13.251
    Property/Plant/Equipment, Total - Net 0.919 0 0.001
    Intangibles, Net 0
    Other Long Term Assets, Total 0.458 0.155 0
    Total Current Liabilities 1.789 1.061 0.877 0.75 1.153
    Payable/Accrued 0.447 0.381 0.567 0.068 0.132
    Accrued Expenses 1.342 0.68 0.31 0.682 0.732
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0
    Other Current Liabilities, Total 0 0.289
    Total Liabilities 2.469 1.061 0.877 0.75 1.153
    Total Long Term Debt 0 0 0 0 0
    Capital Lease Obligations
    Other Liabilities, Total 0.68 0
    Total Equity 73.767 101.595 29.618 10.532 12.098
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.00055 0.009 0.003 0 0.001
    Additional Paid-In Capital 262.97 265.624 186.482 155.062 152.444
    Retained Earnings (Accumulated Deficit) -185.881 -163.774 -156.603 -144.266 -140.083
    Treasury Stock - Common -3.322 -0.264 -0.264 -0.264 -0.264
    Total Liabilities & Shareholders’ Equity 76.236 102.656 30.495 11.282 13.251
    Total Common Shares Outstanding 5.01708 5.27505 2.05401 0.28384 0.11823
    Total Preferred Shares Outstanding 0.00466 0.00466 0.00556 0.00556 0.00556
    Long Term Investments 23.103 9.465 2.764 10.153 10.345
    Cash 33.174 69.763 2.715
    Total Receivables, Net 7.474 6.984
    Accounts Receivable - Trade, Net 7.474 6.984
    Note Receivable - Long Term 1.1 2.147
    Other Equity, Total -0.00055
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 44.771 50.656 56.092 61.563 99.181
    Cash and Short Term Investments 33.94 42.317 46.754 52.867 68.57
    Cash & Equivalents 38.791
    Short Term Investments 24.407 9.143 8.065 9.883 14.69
    Prepaid Expenses 0.745 0.865 0.693 0.196 0.348
    Total Assets 74.154 76.236 84.447 88.296 117.946
    Long Term Investments 23.103 23.103 26.089 25.478 18.61
    Note Receivable - Long Term 1.85 1.1 1.1 1.1 0
    Total Current Liabilities 1.72 1.789 1.899 0.829 0.895
    Payable/Accrued 0.641 0.447 0.518 0.142 0.209
    Accrued Expenses 0.955 1.342 1.381 0.687 0.686
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 5.083 2.469 2.6 0.829 0.895
    Total Long Term Debt 0 0 0 0 0
    Total Equity 69.071 73.767 81.847 87.467 117.051
    Preferred Stock - Non Redeemable, Net 0 0 0 0 22
    Common Stock 0.00048 0.00055 0.00055 0.00052 0.009
    Additional Paid-In Capital 259.215 262.97 262.973 261.603 262.615
    Retained Earnings (Accumulated Deficit) -189.643 -185.881 -178.625 -172.386 -167.309
    Treasury Stock - Common -0.501 -3.322 -2.501 -1.75 -0.264
    Total Liabilities & Shareholders’ Equity 74.154 76.236 84.447 88.296 117.946
    Total Common Shares Outstanding 4.75545 5.01708 5.14011 5.00395 5.25224
    Total Preferred Shares Outstanding 0.00466 0.00466 0.00466 0.00466 0.00466
    Cash 9.533 33.174 38.689 4.193 53.88
    Total Receivables, Net 6.536 7.474 8.645 8.5 9.31
    Accounts Receivable - Trade, Net 6.536 7.474 8.645 8.5 9.31
    Other Long Term Assets, Total 0.458 0.458 0.458 0.155 0.155
    Other Current Assets, Total 3.55 20.953
    Other Equity, Total -0.00048 -0.00055 -0.00055 -0.00052
    Property/Plant/Equipment, Total - Net 3.972 0.919 0.708
    Other Liabilities, Total 3.363 0.68 0.701
    Other Current Liabilities, Total 0.124
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -22.107 -7.171 -12.337 -4.183 1.727
    Cash From Operating Activities -10.597 -6.603 -4.021 -3.017 -2.729
    Cash From Operating Activities 0.038
    Amortization 1.405
    Non-Cash Items 11.949 1.018 8.073 1.38 -5.924
    Cash Interest Paid 0
    Changes in Working Capital -0.439 -0.45 0.243 -0.214 0.025
    Cash From Investing Activities -14.598 -8.853 -24.963 1.256 -0.151
    Capital Expenditures -1.833 -0.617 -1.469 -0.36 -0.036
    Other Investing Cash Flow Items, Total -12.765 -8.236 -23.494 1.616 -0.115
    Cash From Financing Activities -7.193 78.303 31.608 1.835 2.7
    Financing Cash Flow Items -22.026 0 -0.106
    Issuance (Retirement) of Stock, Net 14.833 78.303 31.608 1.941 2.7
    Net Change in Cash -32.388 62.847 2.624 0.074 -0.18
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -3.762 -22.107 -14.851 -8.612 -3.535
    Cash From Operating Activities -3.991 -10.597 -8.735 -5.872 -3.836
    Non-Cash Items 0.283 11.949 6.533 3.21 -0.029
    Changes in Working Capital -0.519 -0.439 -0.417 -0.47 -0.272
    Cash From Investing Activities -18.711 -14.598 -15.959 -15.278 -10.078
    Capital Expenditures -0.361 -1.833 -0.525 0 0
    Other Investing Cash Flow Items, Total -18.35 -12.765 -15.434 -15.278 -10.078
    Cash From Financing Activities -0.939 -7.193 -6.372 -5.621 18.991
    Issuance (Retirement) of Stock, Net -0.939 14.833 15.654 16.405 18.991
    Net Change in Cash -23.641 -32.388 -31.066 -26.771 5.077
    Financing Cash Flow Items -22.026 -22.026 -22.026
    Cash From Operating Activities 0.007

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Dominari Holdings Inc. Company profile

    Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Alkido Pharma Inc.Incorporated and changed its name toDominari Holding Inc. in December 2022.
    Industry: Biotechnology & Medical Research (NEC)

    One Rockefeller Plaza, 11Th Floor
    NEW YORK
    NEW YORK 10020
    US

    Income Statement

    • Annual
    • Quarterly

    News

    How to Trade The Triple Top

    Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

    14:13, 27 September 2023
    USA flag on the background of stock charts. Financial system in USA

    Q4 lookahead: US indices starting to show signs of trouble?

    US indices start to draw attention as traders focus on the outlook for Q4.

    07:20, 27 September 2023

    USD/JPY Climbs Towards Key Highs

    USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

    11:32, 26 September 2023

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    People also watch

    BTC/USD

    27,986.35 Price
    +3.280% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 85.00

    ETH/USD

    1,732.70 Price
    +3.020% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    DE40

    15,415.90 Price
    +0.330% 1D Chg, %
    Long position overnight fee -0.0214%
    Short position overnight fee -0.0008%
    Overnight fee time 21:00 (UTC)
    Spread 8.0

    US100

    14,805.20 Price
    +0.440% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0039%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading